Manish Maski
Company: Sanofi
Job title: Head, Global Rare Nephrology Medical Affairs
Seminars:
Chair’s Closing Remarks 4:30 pm
day: Day One
Panel Discussion: Navigating Earlier Endpoint Development to Predict Clinical Outcome in Shorter Clinical Trials 11:30 am
Can we move towards harmonizing global regulatory endpoints? Non-invasive imaging, patient-reported outcomes, albuminuria and UACR: driving progress in elevating alternative outcome measures Can we incorporate patient reported outcomes in symptomatic kidney diseases?Read more
day: Day One
Moving Beyond a Blanket Approach to Acceptable Endpoints in Rare Kidney Disease 11:00 am
Rethinking approaches to clinical endpoints to reflect the complexity of heterogeneous patient groups in rare diseases How can real-world data be utilised to demonstrate long term efficacy and safety? Leveraging improved understanding of disease heterogeneity to advance research for alternate endpoint developmentRead more
Chair’s Opening Remarks 8:25 am
day: Day One